Monopar Therapeutics Inc. (MNPR)
NASDAQ·Healthcare·Biotechnology
$90.80
-7.29%
Mkt Cap $646.26M
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (19 analysts)
$118.00
Range $105.00 – $125.00
Implied Upside
+30.0%
Consensus $118.00 vs current $90.80
NASDAQ·Healthcare·Biotechnology
$90.80
-7.29%
Mkt Cap $646.26M
Buy
7
Hold
1
Sell
0
Price Target (19 analysts)
$118.00
Range $105.00 – $125.00
+30.0%
Consensus $118.00 vs current $90.80